Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
national blog main
life sciences
biotech
san francisco blog main
san diego blog main
san diego top stories
san francisco top stories
boston blog main
boston top stories
new york blog main
new york top stories
startups
national top stories
clinical trials
deals
wisconsin blog main
wisconsin top stories
cancer
detroit blog main
eli lilly
fda
national
raleigh-durham blog main
raleigh-durham top stories
texas blog main
texas top stories
detroit top stories
indiana blog main
indiana top stories
medical device
seattle blog main
seattle top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
san diego
boehringer ingelheim
investing
medicare
pfizer
What
companies
24
×
life
new
bio
science
drug
ipo
roundup
san
week
biotech
cancer
medicines
raised
sciences
startup
awards
based
deal
diego
disease
hasn’t
latest
leading
pharmaceutical
research
street
therapeutics
therapies
wall
ago
annual
approval
approved
big
biotechs
black
company
days
devices
Language
unset
Current search:
xconomy.com
×
companies
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@xconomy.com
4 years ago
Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer
@xconomy.com
4 years ago
California Life Sciences Fueled by Education, Established Companies
@xconomy.com
4 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
4 years ago
Meet the Xconomy Awards San Diego Digital Trailblazer Finalists
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Connect Honors 7 New Products as ‘Most Innovative’ at Annual Awards
@xconomy.com
5 years ago
After Deal Stalled, Shine Medical Eyeing Up to $160M from Deerfield
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Nominations Open for San Diego’s Inaugural Xconomy Awards
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M
@xconomy.com
5 years ago
Quest Analytics Buys Healthcare Compliance Software Firm BetterDoctor
@xconomy.com
5 years ago
Austin’s Ambiq Micro Adds $11M for Energy-Efficient Microcontrollers
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines
@xconomy.com
5 years ago
Startup CureMatch Wins $35,000 Grand Prize in Global Trade Pitchfest